Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
Beta-adrenoceptor Activation Reduces Host Viral Resistance by Preventing IFN-γ Production in Liver NK Cells
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Novel TRAIL+ NK Cell Subset May Restrain Autoreactivity in Viral Infections: Implications For Sjogren’s Disease and Virus-Induced AutoimmunityFebruary 3, 2015
Monogenic immune defects in type I interferon pathways as a risk factor for severe COVID-19 pneumoniaJanuary 29, 2021
High Affinity Human Antibody Component Identified as a Potential Targeted SARS-Cov-2 TherapyNovember 3, 2020
Cool Housing Temperature and Cold Stress Linked To Immunosuppression and Increased Tumor Growth in Experimental AnimalsMay 12, 2014
Afferent Vagus Nerve Stimulation Activates Brain Locus Coeruleus and Improves Experimental Joint InflammationJuly 18, 2017
The European Commission Approves Remdesivir for the Treatment of Severe Cases of COVID-19July 4, 2020
Production of immunomodulatory and anti-inflammatory neuropeptides by specific gut microbiota genera: in silico evidenceMay 7, 2019
Identification of GM-SCF as possible distinctive blood marker predicting severe COVID-19March 23, 2021
